Day: March 22, 2022

MorphoSys and Incyte Announce Swissmedic Temporary Approval of Minjuvi(R) (tafasitamab) in Combination with Lenalidomide for the Treatment of Adults with r/r DLBCL

MorphoSys and Incyte Announce Swissmedic Temporary Approval of Minjuvi(R) (tafasitamab) in Combination with Lenalidomide for the Treatment of Adults with...

Industry-Leader Savage Enterprises Debuts Premium Cannabis Dispensary, Extrax Palm Springs, Under Its Flagship Delta-8 Brand, Delta Extrax

IRVINE, CA / ACCESSWIRE / March 22, 2022 / Award-winning e-liquid and cannabinoid-infused products manufacturer Savage Enterprises ("Savage") (www.SavageEnterprises.com) announced...

error: Content is protected !!